Fusion inhibitors for HIV

Examples

Generic Name	Brand Name
enfuvirtide	Fuzeon

Enfuvirtide is available only as an injection. It is taken 2 times each day—once in the morning and then again 12 hours later.

How It Works

When HIV invades your body, it attaches to the outside of a CD4+ cell (a type of white blood cell) where it joins (fuses) with the cell and then multiplies. Fusion inhibitors prevent fusion between the virus and the cell from occurring. Therefore, HIV is unable to infect the cell and multiply.

Why It Is Used

Enfuvirtide is used in combination with other antiretroviral medications for the treatment of HIV to prevent the virus from spreading in the body and to reduce the amount of virus in your blood (viral load). Enfuvirtide may be effective for people who have taken other anti-HIV drugs without success.

How Well It Works

Enfuvirtide strengthens the immune system by reducing the amount of virus in the blood.¹

Side Effects

Common side effects of enfuvirtide include skin itchiness, swelling, and pain at the site of the injection. Other side effects may include fatigue, numbness in feet or legs, dizziness, and insomnia.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

Enfuvirtide must be used in combination with other anti-HIV drugs.

Enfuvirtide is approved for people who have already been taking other anti-HIV medications; it is not intended for use by people who are just starting drug treatment for HIV infection.

Enfuvirtide is available only as an injection. It is taken 2 times each day—once in the morning and then again 12 hours later. To prepare each dose, you will need to mix the powdered medication and sterile water, both of which come with the injector.

HIV can become resistant to enfuvirtide, so your viral load and CD4+ cell counts will be closely monitored while you are taking this medication.

This medication is not yet recommended for pregnant or nursing women.

Enfuvirtide is expensive, and insurance coverage may be limited.

Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.

Author:	Douglas Dana Maria G. Essig, MS, ELS	Last Updated: October 10, 2007
Medical Review:	Adam Husney, MD - Family Medicine Anne C. Poinier, MD - Internal Medicine W. David Colby IV, MSc, MD, FRCPC - Infectious Disease Peter Shalit, MD, PhD - Internal Medicine
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.